BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 30685333)

  • 1. A Novel Algorithm to Analyze Epidemiology and Outcomes of Carbapenem Resistance Among Patients With Hospital-Acquired and Ventilator-Associated Pneumonia: A Retrospective Cohort Study.
    Zilberberg MD; Nathanson BH; Sulham K; Fan W; Shorr AF
    Chest; 2019 Jun; 155(6):1119-1130. PubMed ID: 30685333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
    Werarak P; Kiratisin P; Thamlikitkul V
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
    Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS
    J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Distribution of Multidrug-resistant Microorganisms and Treatment Status of Hospital-acquired Pneumonia/Ventilator-associated Pneumonia in Adult Intensive Care Units: a Prospective Cohort Observational Study.
    Chang Y; Jeon K; Lee SM; Cho YJ; Kim YS; Chong YP; Hong SB
    J Korean Med Sci; 2021 Oct; 36(41):e251. PubMed ID: 34697926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventilator-Associated Pneumonia due to Drug-Resistant
    Čiginskienė A; Dambrauskienė A; Rello J; Adukauskienė D
    Medicina (Kaunas); 2019 Feb; 55(2):. PubMed ID: 30781896
    [No Abstract]   [Full Text] [Related]  

  • 6. Emergence of blaNDM-1 and blaVIM producing Gram-negative bacilli in ventilator-associated pneumonia at AMR Surveillance Regional Reference Laboratory in India.
    Kumari M; Verma S; Venkatesh V; Gupta P; Tripathi P; Agarwal A; Siddiqui SS; Arshad Z; Prakash V
    PLoS One; 2021; 16(9):e0256308. PubMed ID: 34495985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for hospital-acquired pneumonia caused by carbapenem-resistant Gram-negative bacteria in critically ill patients: a multicenter study in Korea.
    Kim T; Chong YP; Park SY; Jeon MH; Choo EJ; Chung JW; Lee HK; Moon C; Kim DM; Peck KR; Kim YS
    Diagn Microbiol Infect Dis; 2014 Apr; 78(4):457-61. PubMed ID: 24462178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant gram-negative bacteria.
    Kollef KE; Schramm GE; Wills AR; Reichley RM; Micek ST; Kollef MH
    Chest; 2008 Aug; 134(2):281-287. PubMed ID: 18682456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare-Associated Pneumonia and Hospital-Acquired Pneumonia: Bacterial Aetiology, Antibiotic Resistance and Treatment Outcomes: A Study From North India.
    Kumar S; Jan RA; Fomda BA; Rasool R; Koul P; Shah S; Khan UH; Qadri SM; Masoodi SR; Mantoo S; Muzamil M
    Lung; 2018 Aug; 196(4):469-479. PubMed ID: 29691645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiology, empiric therapy and its impact on the outcomes of nonventilated hospital-acquired, ventilated hospital-acquired, and ventilator-associated bacterial pneumonia in the United States, 2014-2019.
    Zilberberg MD; Nathanson BH; Puzniak LA; Shorr AF
    Infect Control Hosp Epidemiol; 2022 Mar; 43(3):277-283. PubMed ID: 35322770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbapenem Antibiotics for the Empiric Treatment of Nosocomial Pneumonia: A Systematic Review and Meta-analysis.
    Howatt M; Klompas M; Kalil AC; Metersky ML; Muscedere J
    Chest; 2021 Mar; 159(3):1041-1054. PubMed ID: 33393468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of clinical outcomes in patients with bloodstream infections due to Gram-negative bacteria according to carbapenem MIC stratification.
    Esterly JS; Wagner J; McLaughlin MM; Postelnick MJ; Qi C; Scheetz MH
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4885-90. PubMed ID: 22777044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a bedside tool to predict the probability of drug-resistant pathogens among hospitalized adult patients with gram-negative infections.
    Lodise TP; Bonine NG; Ye JM; Folse HJ; Gillard P
    BMC Infect Dis; 2019 Aug; 19(1):718. PubMed ID: 31412809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution and antibiotic susceptibility of pathogens isolated from adults with hospital-acquired and ventilator-associated pneumonia in intensive care unit.
    Djordjevic ZM; Folic MM; Jankovic SM
    J Infect Public Health; 2017; 10(6):740-744. PubMed ID: 28189513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging trends of nosocomial pneumonia in intensive care unit of a tertiary care public teaching hospital in Western India.
    Bhadade R; Harde M; deSouza R; More A; Bharmal R
    Ann Afr Med; 2017; 16(3):107-113. PubMed ID: 28671150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial pneumonia associated with multidrug-resistant Gram-negative pathogens: Understanding epidemiology, resistance patterns, and implications with COVID-19.
    Hammoudi Halat D; Ayoub Moubareck C
    F1000Res; 2023; 12():92. PubMed ID: 38915769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nosocomial and ventilator-associated pneumonia in a community hospital intensive care unit: a retrospective review and analysis.
    Behnia M; Logan SC; Fallen L; Catalano P
    BMC Res Notes; 2014 Apr; 7():232. PubMed ID: 24725655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-drug versus combination antimicrobial therapy in critically ill patients with hospital-acquired pneumonia and ventilator-associated pneumonia due to Gram-negative pathogens: a multicenter retrospective cohort study.
    Barbier F; Dupuis C; Buetti N; Schwebel C; Azoulay É; Argaud L; Cohen Y; Hong Tuan Ha V; Gainnier M; Siami S; Forel JM; Adrie C; de Montmollin É; Reignier J; Ruckly S; Zahar JR; Timsit JF;
    Crit Care; 2024 Jan; 28(1):10. PubMed ID: 38172969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attributable burden in patients with carbapenem-nonsusceptible gram-negative respiratory infections.
    Tabak YP; Sung A; Ye G; Vankeepuram L; Gupta V; McCann E
    PLoS One; 2020; 15(2):e0229393. PubMed ID: 32084236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations.
    Katchanov J; Asar L; Klupp EM; Both A; Rothe C; König C; Rohde H; Kluge S; Maurer FP
    PLoS One; 2018; 13(4):e0195757. PubMed ID: 29649276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.